Women’s Health Therapeutics Market Segmentation, Growth Rate Report, Various Strategies & Analysis to 2020-2027
Global Women’s Health
Therapeutics Market
Therapeutics is defined as the treatment & care of
patient for the purpose of both preventing and combating disease or injury.
Women’s health therapeutics includes precautionary measures for the
various disorders associated with the women population. These disorders vary
from oncology, urological, menopause, reproductive, and other healthcare
application. Women’s health therapeutics is focused on providing better
management of diseases as well as improving the overall health of women
population. The rise in prevalence of chronic and lifestyle-associated
disorders in women is expected to boost the market growth.
Women’s health therapeutics has been gaining significance
from past few years. For Instance, in 1991, National Heart, Lung, and Blood
Institute of the U.S. National Institutes of Health sponsored the Women’s
Health Initiative. This initiative focusses on various strategies such as
prevention of colorectal cancer, osteoporosis, breast cancer, and heart
disorders in postmenopausal women over the long term. Women’s Health Initiative
is divided into mainly three parts clinical study, observational research, and
community prevention study.
Get Request Sample
copy @ https://qualiketresearch.com/request-sample/Womens-Health-Therapeutics-Market/request-sample
The data collection for this initiative was completed in the
year 2005 by National Institutes of Health (NIH). Also, the Women Health
Initiative contributes WHI contributes majorly towards women’s health as well
as therapeutics by ancillary studies. Launch of WHI (Women’s Health Initiative)
has been completed around 30 years and its data are still going strong,
producing key findings which is expected to boost the growth of women health
therapeutics industry.
Furthermore, the increase in healthcare investment for early
detection of cancer & infectious diseases, complications related to the
pregnancy, are expected drive the market growth. In addition, the increase in
awareness regarding the cancer, osteoporosis, menopause, and infections is
expected to propel the global Women’s Health Therapeutics Market growth over
the forecast period. Moreover, the introduction of new drug therapies by key
operating players will positively influence the market growth. For instance, in
October 2020, GSK Plc received the European Commission approval for Zejula
(niraparib), which is used for the treatment of advanced ovarian cancer.
High costs associated with the clinical services is act as
major restraint which expected to hamper the global women’s health therapeutics
market growth throughout the forecast period. Also, certain side effects
associated with the usage of drugs will also hinder the global women’s health
therapeutics market growth. In addition, expiration of certain patents of
pharmaceuticals may limit the market growth. Some drugs whose patent has
expired or soon to be expired are the Premarin family, Mirena, Actonel, Forteo,
Boniva, Gonal-F.
Market Segmentation
On the basis of type, the Global Women’s Health Therapeutics
Market is segmented into pregnancy, infection, and oncology. Oncology is
sub-segmented into ovarian, cervical, uterine, and vaginal and vulvar cancer.
The infection segment dominated the market, owing to the increase in incidence
of bacterial vaginosis, TB (Tuberculosis), herpes simplex virus,
cytomegalovirus, toxoplasmosis, urinary tract infection (UTI), and hepatitis A,
B, C, D, and E. As per the information provided by Centers for Disease Control
and Prevention, bacterial vaginosis (BV) is the most prevalent infection among
women in United Sates, affecting approximately 21.2 million women
annually.
Cervical cancer is expected to hold a majority of revenue
share within oncology segment in overall women’s health therapeutics market
throughout the forecast period. New product approvals, launches, increase in
clinical trials, & available reimbursement for better & effective
treatment are some driving factors for the market expansion.
Also, the market is segmented into application such as
Diagnostic and imaging centres, Hospitals and clinics, and Home care.
Regional Analysis
Global Women’s Health Therapeutics Market is segmented into
five regions such as North America, Latin America, Europe, Asia Pacific, and
Middle East & Africa.
The North America held the largest revenue share in the in
the overall market followed by Europe. Due to the increase in cases of chronic
diseases, growing funding, and mergers & acquisitions in the region. For
instance, in August 2020, Bayer had completed acquisition of KaNDy
Therapeutics, UK Based biotech company for the development of women’s healthcare
product pipeline. The Asia Pacific is expected to grow at a fastest rate during
the forecast period. Due to the increase in awareness about women’s health,
increasing prevalence of infertility, osteoarthritis, and other disorders due
to stress.
Key Players Analysis
The key operating players of Women’s health therapeutics
market includes GSK, Abbott Laboratories, Novartis International AG, Pfizer,
Inc., Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and
Company, Agile Therapeutics, AstraZeneca etc. Product Launch, merger and
acquisition, and partnership are some key strategies adopted by the key players
& sustain and capture the market share in the global women’s health
therapeutics market.
Market Taxonomy
By Type
·
Pregnancy
·
Infection
·
Oncology
·
Ovarian
·
Cervical
·
Uterine
·
Vaginal and Vulvar Cancer
By Application
·
Diagnostic and imaging centres
·
Hospitals and clinics
·
Home care
By Region
·
North America
·
Latin America
·
Europe
·
Asia Pacific
·
Middle East & Africa
Get Full Report
Analysis @ https://qualiketresearch.com/reports-details/Womens-Health-Therapeutics-Market
About Us
QualiKet Research is a leading Market Research and
Competitive Intelligence partner helping leaders across the world to develop
robust strategy and stay ahead for evolution by providing actionable insights
about ever changing market scenario, competition and customers. QualiKet
Research is dedicated to enhancing the ability of faster decision making by
providing timely and scalable intelligence. We use different intelligence tools
to come up with evidence that showcases the threats and opportunities which
help our clients outperform their competition.
Comments
Post a Comment